Skip to main content
Top
Published in: BMC Geriatrics 1/2022

Open Access 01-12-2022 | Correction

Correction to: Polypharmacy and deprescribing: Challenging the old and embracing the new

Authors: Lisa Kouladjian O’Donnell, Kinda Ibrahim

Published in: BMC Geriatrics | Issue 1/2022

Login to get access

Excerpt

Following publication of the original article [1], it was reported that there was a typographical error in the reference to the English Deprescribing Network, EdEN. This was erroneously referred to as the European Desprescribing Network. …
Metadata
Title
Correction to: Polypharmacy and deprescribing: Challenging the old and embracing the new
Authors
Lisa Kouladjian O’Donnell
Kinda Ibrahim
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2022
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-022-03465-x

Other articles of this Issue 1/2022

BMC Geriatrics 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine